ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0,49
-0,03
(-5,77%)
Geschlossen 31 März 10:00PM
0,5079
0,0179
(3,65%)
Nach Börsenschluss: 12:59AM
Fortg. Diagramm

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,5079
Gebot
0,492
Fragen
0,7999
Volumen
23.095.544
0,50 Tagesbereich 0,67
0,491 52-Wochen-Bereich 66,33
Marktkapitalisierung
Handelsende
0,52
Handelsbeginn
0,6027
Letzter Handelszeitpunkt
Finanzvolumen
US$ 13.223.083
VWAP
0,572538
Durchschnittliches Volumen (3 Mio.)
6.936.968
Ausgegebene Aktien
696.233
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,02
Gewinn pro Aktie (EPS)
-26,64
Erlöse
-
Nettogewinn
-18,55M

Über TransCode Therapeutics Inc

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
TransCode Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAZ. The last closing price for TransCode Therapeutics was US$0,52. Over the last year, TransCode Therapeutics shares have traded in a share price range of US$ 0,491 to US$ 66,33.

TransCode Therapeutics currently has 696.233 shares in issue. The market capitalisation of TransCode Therapeutics is US$362.041,16 . TransCode Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

RNAZ Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.4823-48.70733185220.99021.670.491495586321.0563992CS
4-1.9921-79.6842.52.540.491149035281.0427656CS
12-3.0281-85.63631221723.53616.730.49169369682.9327181CS
26-20.2821-97.55699855720.7926.40.49135807114.51667887CS
52-21.8958-97.732963751522.403766.330.49125293879.76361251CS
156-70487.4921-99.999279451870488813120.49120207695008.94752442CS
260-158399.4921-99.99967935611584001848000.491195415922004.2682041CS

RNAZ - Frequently Asked Questions (FAQ)

What is the current TransCode Therapeutics share price?
The current share price of TransCode Therapeutics is US$ 0,5079
How many TransCode Therapeutics shares are in issue?
TransCode Therapeutics has 696.233 shares in issue
What is the market cap of TransCode Therapeutics?
The market capitalisation of TransCode Therapeutics is USD 362,04k
What is the 1 year trading range for TransCode Therapeutics share price?
TransCode Therapeutics has traded in the range of US$ 0,491 to US$ 66,33 during the past year
What is the PE ratio of TransCode Therapeutics?
The price to earnings ratio of TransCode Therapeutics is -0,02
What is the reporting currency for TransCode Therapeutics?
TransCode Therapeutics reports financial results in USD
What is the latest annual profit for TransCode Therapeutics?
The latest annual profit of TransCode Therapeutics is USD -18,55M
What is the registered address of TransCode Therapeutics?
The registered address for TransCode Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the TransCode Therapeutics website address?
The website address for TransCode Therapeutics is www.transcodetherapeutics.com
Which industry sector does TransCode Therapeutics operate in?
TransCode Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PRTGPortage Biotech Inc
US$ 9,60
(103,82%)
29,92M
LXRXLexicon Pharmaceuticals Inc
US$ 0,5741
(65,16%)
405,3M
DBVTDBV Technologies SA
US$ 6,12
(56,52%)
21,8M
MYSZMy Size Inc
US$ 1,79
(42,06%)
11,89M
LXEHLixiang Education Holding Company Ltd
US$ 17,70
(32,78%)
217,53k
STSSSharps Technology Inc
US$ 0,0421
(-72,43%)
214,43M
MISTMilestone Pharmaceuticals Inc
US$ 0,88
(-60,89%)
33,47M
XTIAXTI Aerospace Inc
US$ 1,23
(-50,00%)
1,82M
LGMKLogicMark Inc
US$ 0,0258
(-49,41%)
161,36M
ICONIcon Energy Corporation
US$ 0,0516
(-48,40%)
27,6M
LXRXLexicon Pharmaceuticals Inc
US$ 0,5741
(65,16%)
405,29M
DMNDamon Inc
US$ 0,0346
(-22,42%)
314,35M
NVDANVIDIA Corporation
US$ 109,67
(-1,58%)
229,88M
STSSSharps Technology Inc
US$ 0,0421
(-72,43%)
214,43M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,845
(-7,30%)
200,21M

RNAZ Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock